Evaluation of Immunogenicity, Safety and Antibody Persistence of COVID-19 Booster Vaccine (Produced in Wuhan) in Patients With Hypertension and/or Diabetes

NCT05104437 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

1440

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19 Pneumonia

Interventions

BIOLOGICAL: Covid-19 vaccine (0-1-4 schedule)
BIOLOGICAL: Covid-19 vaccine (0-1-6 schedule)

Sponsor

China National Biotec Group Company Limited

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]